Please select one of the following
Following medical guidelines, both UACR and eGFR are critical for taking timely action against renal damage and CV risk1,2
ADA guidelines established a treatment target for UACR which recommends that UACR should be reduced by at least 30% in patients with CKD and T2D and a UACR level above 300mg/g1-3
Patients with T2D who have albuminuria may be suitable for additional treatment, even if their eGFR is preserved, to protect against deadly CV events and limit further kidney damage1-3
Thank you for visiting our site. The questions you'll see throughout are completely voluntary.
When leveraged together, increasing levels of albuminuria and reduced rates of eGFR indicate clinical manifestations of kidney damage and increased CV risk2
ADA=American Diabetes Association; CKD=chronic kidney disease; CV=cardiovascular; eGFR=estimated glomerular filtration rate; GFR=glomerular filtration rate; KDIGO=Kidney Disease Improving Global Outcomes; T2D=type 2 diabetes; UACR=urine albumin-to-creatinine ratio.